No Data
No Data
Viking Stock Jumps After Company Speeds Development Its Weight-Loss Pill -- Barrons.com
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 15 Years
Viking Therapeutics Stock Jumps 16% After Drugmaker Moves Weight Loss Injection to Late-stage Trial
Cantor Fitzgerald Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $885
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
Express News | Eli Lilly and Novo Nordisk Shares Are Trading Lower After Competitor Viking Announced the Advancement of Its Obesity Candidate
No Data